Tammy Ladduwahetty

Statistics

Publications

Citations

106

H-Index

Active since

2022

Affiliations

Charles River Laboratories (United Kingdom)(Current)

CHDI Foundation

Tammy Ladduwahetty is an author at Charles River Laboratories (United Kingdom) specializing in neurodegenerative disorders, huntingtin aggregation, and neurodegenerative diseases.

ORCID

Publications per year

2022–2022

Publications

Small-Molecule Inhibition of the Acyl-Lysine Reader ENL as a Strategy against Acute Myeloid Leukemia

Yiman Liu, Qinglan Li, Fatemeh Alikarami‬ et al. · Cancer Discovery · 2022 · 60 citations · Full text

Medicine, Cancer Biology, Oncology +17

Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington’s Disease Pathology

Natsuko Macabuag, William Esmieu, Perla Breccia et al. · Journal of Medicinal Chemistry · 2022 · 32 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington’s Disease

Tammy Ladduwahetty, Matthew R. Lee, Michel Maillard et al. · Journal of Medicinal Chemistry · 2022 · 14 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–3 of 3